The clinical presentation of our patient with SPATA5L1 variants shows considerable overlap with previously reported cases of SPATA5L1-related neurodevelopmental disorders characterized by hearing impairment and neurological manifestations [1,3,4]. This evidence concerns the gene AFG2B and hearing loss disorder.